Prospects of apoptotic cell-based therapies for transplantation and inflammatory diseases.

Date publication

octobre 2013

Auteurs

Membres identifiés du Cancéropôle Est :
Dr PERRUCHE Sylvain

Tous les auteurs :
Saas P, Kaminski S, Perruche S

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/24088076

Résumé

Apoptotic cell removal or interactions of early-stage apoptotic cells with immune cells are associated with an immunomodulatory microenvironment that can be harnessed to exert therapeutic effects. While the involved immune mechanisms are still being deciphered, apoptotic cell infusion has been tested in different experimental models where inflammation is deregulated. This includes chronic and acute inflammatory disorders such as arthritis, contact hypersensitivity and acute myocardial infarction. Apoptotic cell infusion has also been used in transplantation settings to prevent or treat acute and chronic rejection, as well as to limit acute graft-versus-host disease associated with allogeneic hematopoietic cell transplantation. Here, we review the mechanisms involved in apoptotic cell-induced immunomodulation and data obtained in preclinical models of transplantation and inflammatory diseases.

Référence

Immunotherapy. 2013 Oct;5(10):1055-73